Analyst Alan Carr of Needham weighed in on Intercept Pharmaceuticals (NASDAQ:ICPT) and Cempra Inc (NASDAQ:CEMP) today. Intercept Pharmaceuticals Carr maintains a Buy rating on …
In a research report issued yesterday, Needham analyst Alan Carr reiterated a Buy rating on shares of Cempra Inc (NASDAQ:CEMP), with a price target …
McDonald’s Corporation (NYSE:MCD) is up 6.50% in pre-market trading to $109.
In a research report issued Tuesday, Leerink Swann analyst Paul Matteis initiated coverage on shares of Cempra Inc (NASDAQ:CEMP), with a Market Perform …
In light of upcoming events in the biotechnology sector slated for the fourth quarter of this year, Needham analyst Alan Carr weighed in …
Cempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today …
Roth Capital’s healthcare analyst Debjit Chattopadhyay weighed in today with his views on Cempra Inc (NASDAQ:CEMP), following the news that Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)’s IGNITE2 phase …
Roth Capital analyst Debjit Chattopadhyay issued a note to investors on August 25 highlighting the recent stock market drop. However, the analyst found …
